The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

Yinon Ben-Neriah*, George Q. Daley, Anne Marie Mes-Masson, Owen N. Witte, David Baltimore

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

697 Scopus citations

Fingerprint

Dive into the research topics of 'The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Keyphrases